Moral Hazard and the Pharmaceutical Benefits Scheme. The extent and significance of moral hazard in the PBS is an issue of significance for all Australians. Pharmaceuticals are a central feature in maintaining the health of Australians and with factors such as an ageing population and technological advances the centrality of pharmaceuticals is likely to be consolidated One, if not the, major challenge will be how to provide pharmaceuticals efficiently, equitably and sustainably. If significant a ....Moral Hazard and the Pharmaceutical Benefits Scheme. The extent and significance of moral hazard in the PBS is an issue of significance for all Australians. Pharmaceuticals are a central feature in maintaining the health of Australians and with factors such as an ageing population and technological advances the centrality of pharmaceuticals is likely to be consolidated One, if not the, major challenge will be how to provide pharmaceuticals efficiently, equitably and sustainably. If significant and extensive, moral hazard potentially compromises PBS efficiency and threatens sustainability. The proposed project represents a significant empirical contribution to understanding the impact of moral hazard on the PBS and will make a significant contribution towards making the PBS sustainableRead moreRead less
Harm-minimisation policies and the economics of controlling illicit drug use. The use of illicit drugs and its consequences are of major concern in Australia. Policies seeking to directly curb illicit drug use have met with mixed success and, over time, pressure has been placed on policymakers to switch toward increased reliance on harm-minimisation policies. This switch can generate adverse incentive effects by reducing the user costs of illicit drug use which acts to increase illicit drug use. ....Harm-minimisation policies and the economics of controlling illicit drug use. The use of illicit drugs and its consequences are of major concern in Australia. Policies seeking to directly curb illicit drug use have met with mixed success and, over time, pressure has been placed on policymakers to switch toward increased reliance on harm-minimisation policies. This switch can generate adverse incentive effects by reducing the user costs of illicit drug use which acts to increase illicit drug use. Cost-effectively mitigating these adverse incentive effects can improve the effectiveness of policy by promoting harm- minimisation without seriously sacrificing drug use abstinence objectives. Read moreRead less